-
enhance our understanding of disease-relevant cis-acting elements and trans-acting effector proteins and metabolites. With the knowledge generated from these analyses you will work to develop more precise
-
the scientific component of this posting, please contact Dr. Marieta Pehlivanova via email at mp8ce@uvahealth.org . This is an Exempt level, benefited position. For more information on the benefits at UVA, visit
-
myeloid cells, a critical component of the body defense against infections, and how abnormalities in this regulation contribute to failure in myeloid cell maturation resulting in acute myeloid leukemia
-
the Fellow. Requirements: Applicants must have a PhD. Candidates who received (or will receive) their PhD between August 24, 2022 and August 24, 2025 are eligible to apply. The RPE component specifically seeks